Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Current Leases: 2022-2024

Historic Current Leases for Oncology Institute (TOI) over the last 3 years, with FY2024 value amounting to $6.8 million.

  • Oncology Institute's Current Leases rose 610.46% to $7.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.2 million, marking a year-over-year increase of 610.46%. This contributed to the annual value of $6.8 million for FY2024, which is 683.64% up from last year.
  • As of FY2024, Oncology Institute's Current Leases stood at $6.8 million, which was up 683.64% from $6.4 million recorded in FY2023.
  • Oncology Institute's 5-year Current Leases high stood at $6.8 million for FY2024, and its period low was $5.5 million during FY2022.
  • Moreover, its 3-year median value for Current Leases was $6.4 million (2023), whereas its average is $6.2 million.
  • Its Current Leases has fluctuated over the past 5 years, first soared by 1573.3% in 2023, then soared by 683.64% in 2024.
  • Over the past 3 years, Oncology Institute's Current Leases (Annual) stood at $5.5 million in 2022, then rose by 15.73% to $6.4 million in 2023, then grew by 6.84% to $6.8 million in 2024.
  • Its last three reported values are $6.8 million in FY2024, $6.4 million for FY2023, and $5.5 million during FY2022.